Vasantha Jotwani1, Ronit Katz2, Joachim H Ix3, Orlando M Gutiérrez4, Michael Bennett5, Chirag R Parikh6, Steven R Cummings7, Mark J Sarnak8, Michael G Shlipak9. 1. Division of Nephrology, Department of Medicine, San Francisco VA Medical Center, San Francisco, CA; Kidney Health Research Collaborative, San Francisco VA Medical Center and University of California, San Francisco, CA. Electronic address: vasantha.jotwani@ucsf.edu. 2. Kidney Research Institute, University of Washington, Seattle, WA. 3. Division of Nephrology-Hypertension, Department of Medicine, University of California, San Diego, CA; Nephrology Section, Veterans Affairs San Diego Healthcare System, San Diego, CA. 4. Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, AL. 5. Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 6. Section of Nephrology, Department of Medicine, Yale University, New Haven, CT; Program of Applied Translational Research, Yale University, New Haven, CT. 7. California Pacific Medical Center Research Institute, San Francisco, CA. 8. Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA. 9. Division of Nephrology, Department of Medicine, San Francisco VA Medical Center, San Francisco, CA; Kidney Health Research Collaborative, San Francisco VA Medical Center and University of California, San Francisco, CA.
Abstract
RATIONALE & OBJECTIVE: Novel urinary biomarkers have enabled earlier detection of kidney tubular damage, but their prognostic value for adverse cardiovascular outcomes is uncertain. We hypothesized that tubular damage, measured by urine α1-microglobulin (A1M), amino-terminal propeptide of type III procollagen (PIIINP), and neutrophil gelatinase-associated lipocalin (NGAL), would be associated with higher risks for cardiovascular events and mortality among elders. STUDY DESIGN: Case-cohort study. SETTING & PARTICIPANTS: This study included a randomly selected subcohort (n=502), cardiovascular disease (CVD) cases (n=245), and heart failure cases (n=220) from the Health, Aging, and Body Composition (Health ABC) Study. PREDICTORS: Baseline urine A1M, PIIINP, and NGAL concentrations. OUTCOMES: Incident CVD, heart failure, and all-cause mortality. ANALYTICAL APPROACH: Cox proportional hazards models were used to evaluate biomarker associations with each outcome. RESULTS: At baseline, mean age was 74 years and estimated glomerular filtration rate was 73mL/min/1.73m2. After adjustment for demographics, estimated glomerular filtration rate, albumin-creatinine ratio, and other cardiovascular risk factors, each doubling in biomarker concentration was associated with the following adjusted HRs for CVD: A1M, 1.51 (95% CI, 1.16-1.96); PIIINP, 1.21 (95% CI, 1.00-1.46); and NGAL, 1.12 (95% CI, 1.05-1.20). There were 248 deaths in the subcohort during a median follow-up of 12.4 years. Adjusted associations of each biomarker (HR per doubling) with all-cause mortality were: A1M, 1.29 (95% CI, 1.10-1.51); PIIINP, 1.05 (95%, 0.94-1.18); and NGAL, 1.07 (95% CI, 1.02-1.12). Biomarker concentrations did not have statistically significant associations with heart failure after multivariable adjustment. LIMITATIONS: Urine biomarkers were measured at a single time point; no validation cohort available. CONCLUSIONS: Kidney tubular damage is an independent risk factor for CVD and death among elders. Future studies should investigate mechanisms by which kidney tubular damage may adversely affect cardiovascular risk. Published by Elsevier Inc.
RATIONALE & OBJECTIVE: Novel urinary biomarkers have enabled earlier detection of kidney tubular damage, but their prognostic value for adverse cardiovascular outcomes is uncertain. We hypothesized that tubular damage, measured by urine α1-microglobulin (A1M), amino-terminal propeptide of type III procollagen (PIIINP), and neutrophil gelatinase-associated lipocalin (NGAL), would be associated with higher risks for cardiovascular events and mortality among elders. STUDY DESIGN: Case-cohort study. SETTING & PARTICIPANTS: This study included a randomly selected subcohort (n=502), cardiovascular disease (CVD) cases (n=245), and heart failure cases (n=220) from the Health, Aging, and Body Composition (Health ABC) Study. PREDICTORS: Baseline urine A1M, PIIINP, and NGAL concentrations. OUTCOMES: Incident CVD, heart failure, and all-cause mortality. ANALYTICAL APPROACH: Cox proportional hazards models were used to evaluate biomarker associations with each outcome. RESULTS: At baseline, mean age was 74 years and estimated glomerular filtration rate was 73mL/min/1.73m2. After adjustment for demographics, estimated glomerular filtration rate, albumin-creatinine ratio, and other cardiovascular risk factors, each doubling in biomarker concentration was associated with the following adjusted HRs for CVD: A1M, 1.51 (95% CI, 1.16-1.96); PIIINP, 1.21 (95% CI, 1.00-1.46); and NGAL, 1.12 (95% CI, 1.05-1.20). There were 248 deaths in the subcohort during a median follow-up of 12.4 years. Adjusted associations of each biomarker (HR per doubling) with all-cause mortality were: A1M, 1.29 (95% CI, 1.10-1.51); PIIINP, 1.05 (95%, 0.94-1.18); and NGAL, 1.07 (95% CI, 1.02-1.12). Biomarker concentrations did not have statistically significant associations with heart failure after multivariable adjustment. LIMITATIONS: Urine biomarkers were measured at a single time point; no validation cohort available. CONCLUSIONS: Kidney tubular damage is an independent risk factor for CVD and death among elders. Future studies should investigate mechanisms by which kidney tubular damage may adversely affect cardiovascular risk. Published by Elsevier Inc.
Entities:
Keywords:
Urine biomarker; amino-terminal propeptide of type III procollagen (PIIINP); cardiovascular disease (CVD); elderly; heart failure (HF); mortality; neutrophil gelatinase-associated lipocalin (NGAL); prognostication; tubular injury markers; α(1)-microglobulin (A1M)
Authors: Johanna Helmersson-Karlqvist; Anders Larsson; Axel C Carlsson; Per Venge; Johan Sundström; Erik Ingelsson; Lars Lind; Johan Arnlöv Journal: Atherosclerosis Date: 2013-01-18 Impact factor: 5.162
Authors: Michael Bennett; Catherine L Dent; Qing Ma; Sudha Dastrala; Frank Grenier; Ryan Workman; Hina Syed; Salman Ali; Jonathan Barasch; Prasad Devarajan Journal: Clin J Am Soc Nephrol Date: 2008-03-12 Impact factor: 8.237
Authors: Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson Journal: Circulation Date: 2003-10-28 Impact factor: 29.690
Authors: Kathleen D Liu; Wei Yang; Amanda H Anderson; Harold I Feldman; Sevag Demirjian; Takayuki Hamano; Jiang He; James Lash; Eva Lustigova; Sylvia E Rosas; Michael S Simonson; Kaixiang Tao; Chi-yuan Hsu Journal: Kidney Int Date: 2013-01-23 Impact factor: 10.612
Authors: Jonathan G Amatruda; Ronit Katz; Carmen A Peralta; Michelle M Estrella; Harini Sarathy; Linda F Fried; Anne B Newman; Chirag R Parikh; Joachim H Ix; Mark J Sarnak; Michael G Shlipak Journal: J Am Geriatr Soc Date: 2020-12-10 Impact factor: 5.562
Authors: Jonathan G Amatruda; Michelle M Estrella; Amit X Garg; Heather Thiessen-Philbrook; Eric McArthur; Steven G Coca; Chirag R Parikh; Michael G Shlipak Journal: Am J Nephrol Date: 2021-09-02 Impact factor: 3.754
Authors: Sherry G Mansour; Pavan K Bhatraju; Steven G Coca; Wassim Obeid; Francis P Wilson; Ian B Stanaway; Yaqi Jia; Heather Thiessen-Philbrook; Alan S Go; T Alp Ikizler; Edward D Siew; Vernon M Chinchilli; Chi-Yuan Hsu; Amit X Garg; W Brian Reeves; Kathleen D Liu; Paul L Kimmel; James S Kaufman; Mark M Wurfel; Jonathan Himmelfarb; Samir M Parikh; Chirag R Parikh Journal: J Am Soc Nephrol Date: 2022-01-11 Impact factor: 10.121
Authors: Alexandra K Lee; Ronit Katz; Vasantha Jotwani; Pranav S Garimella; Walter T Ambrosius; Alfred K Cheung; Lisa H Gren; Javier A Neyra; Henry Punzi; Kalani L Raphael; Michael G Shlipak; Joachim H Ix Journal: Hypertension Date: 2019-08-05 Impact factor: 10.190
Authors: Vasantha K Jotwani; Alexandra K Lee; Michelle M Estrella; Ronit Katz; Pranav S Garimella; Rakesh Malhotra; Dena E Rifkin; Walter Ambrosius; Barry I Freedman; Alfred K Cheung; Kalani L Raphael; Paul Drawz; Javier A Neyra; Suzanne Oparil; Henry Punzi; Michael G Shlipak; Joachim H Ix Journal: Am J Nephrol Date: 2019-04-02 Impact factor: 3.754
Authors: Vasantha Jotwani; Pranav S Garimella; Ronit Katz; Rakesh Malhotra; Jeffrey Bates; Alfred K Cheung; Michel Chonchol; Paul E Drawz; Barry I Freedman; William E Haley; Anthony A Killeen; Henry Punzi; Mark J Sarnak; Mark S Segal; Michael G Shlipak; Joachim H Ix Journal: Am J Nephrol Date: 2020-09-09 Impact factor: 3.754
Authors: Pranav S Garimella; Alexandra K Lee; Walter T Ambrosius; Udayan Bhatt; Alfred K Cheung; Michel Chonchol; Timothy Craven; Amret T Hawfield; Vasantha Jotwani; Anthony Killeen; Henry Punzi; Mark J Sarnak; Barry M Wall; Joachim H Ix; Michael G Shlipak Journal: Eur Heart J Date: 2019-11-01 Impact factor: 35.855